Bollard Group’s CME Group CME Stock Holding History

Bollard Group’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-25	Closed	-$5K	–	430
2023 Q2	$5K	Buy	+25	New	+$4.62K	﹤0.01%	384
2019 Q2	–	Sell	-205	Closed	-$34K	–	251
2019 Q1	$34K	Buy	205 +3	+1%	+$530	﹤0.01%	218
2018 Q4	$38K	Hold	202	–	–	﹤0.01%	213
2018 Q3	$34K	Buy	202 +1	+0.5%	+$168	﹤0.01%	223
2018 Q2	$33K	Buy	+201	New	+$32.8K	﹤0.01%	220

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Bollard Group's CME Position: Q3 2023 in Review

Bollard Group sold out of CME Group (CME) in Q3 2023, closing a stake of 25 shares — an estimated $5K sold.

Bollard Group first reported a position in CME in Q2 2018 and held it in 5 quarters. The position peaked at $38K in Q4 2018. 1,229 funds tracked by Wall St. Rank hold CME as of Q3 2023.

Bollard Group reported no remaining CME Group position as of Q3 2023 after selling out during the quarter.
Bollard Group sold 25 CME Group shares in Q3 2023, an estimated $5K.
Bollard Group first reported a position in CME Group in Q2 2018 and held it in 5 quarters.
Bollard Group's CME Group position peaked at $38K in Q4 2018.
1,229 funds tracked by Wall St. Rank held CME Group as of Q3 2023.

Based on Bollard Group's 13F filing for Q3 2023, filed 14 Nov 2023.